102 related articles for article (PubMed ID: 8682618)
1. Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV.
Kawanishi M
Intervirology; 1995; 38(3-4):206-13. PubMed ID: 8682618
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines.
Gao X; Tajima M; Sairenji T
Virology; 1999 Jun; 258(2):375-81. PubMed ID: 10366574
[TBL] [Abstract][Full Text] [Related]
3. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
4. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
Lin JC; Raab-Traub N
J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Epstein-Barr virus (EBV) reactivation by short interfering RNAs targeting p38 mitogen-activated protein kinase or c-myc in EBV-positive epithelial cells.
Gao X; Wang H; Sairenji T
J Virol; 2004 Nov; 78(21):11798-806. PubMed ID: 15479821
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition.
Djeraba A; Bernardet N; Dambrine G; Quéré P
Virology; 2000 Nov; 277(1):58-65. PubMed ID: 11062036
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase I and II activities are required for Epstein-Barr virus replication.
Kawanishi M
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2263-8. PubMed ID: 8409949
[TBL] [Abstract][Full Text] [Related]
8. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
9. Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter.
Lin JC; Smith MC; Pagano JS
J Virol; 1983 Mar; 45(3):985-91. PubMed ID: 6300468
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of human hepatocytes in culture to reactive nitrogen intermediates.
D'Ambrosio SM; Oberyszyn TM; Brady T; Ross MS; Robertson FM
Biochem Biophys Res Commun; 1997 Apr; 233(2):545-9. PubMed ID: 9144574
[TBL] [Abstract][Full Text] [Related]
11. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanism of lytic phase of Epstein-Barr virus DNA replication].
Tsurumi T
Nihon Rinsho; 1997 Feb; 55(2):321-7. PubMed ID: 9046818
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes.
Lin JC; Smith MC
Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048
[TBL] [Abstract][Full Text] [Related]
14. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
Boguszaková L; Hirsch I; Brichácek B; Vonka V
J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
[TBL] [Abstract][Full Text] [Related]
16. Suppression of neuropeptide Y1 receptor function in SK-N-MC cells by nitric oxide.
Dötsch J; Hänze J; Beste O; Behrendt J; Weber WM; Dittrich K; Rascher W
Am J Physiol; 1997 Aug; 273(2 Pt 1):C618-21. PubMed ID: 9277359
[TBL] [Abstract][Full Text] [Related]
17. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine.
Lin JC; Smith MC; Pagano JS
Carcinogenesis; 1983; 4(2):185-8. PubMed ID: 6297823
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus induces fragmentation of chromosomal DNA during lytic infection.
Kawanishi M
J Virol; 1993 Dec; 67(12):7654-8. PubMed ID: 8230485
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
